Kalivir Immunotherapeutics, Inc.
KALIVIR is a clinical-stage biopharmaceutical company dedicated to developing systemically deliverable oncolytic virus immunotherapies.
)
February 16-17, 2027 | Miami Beach
)
February 16-17, 2027 | Miami Beach
)
February 16-17, 2027 | Miami Beach
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
